Drag a card by its title · ⚙ to size, swap or remove

The company

Akebia Therapeutics, Inc.

AKBA · Nasdaq

Health CarePharmaceuticalsNot moving yet

AKBA stood above a rising 150-day average in 1 of the last 52 weekly readings, and has been out of that trend for the last 51 weeks. It is 40.6% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 51
Industry in uptrend: 31% -7 in 4 wk
Insider buys, 12 months: $173K
Insider sales, 12 months: $1.9M
Officials’ trades on record: 0
Institutions holding: 164 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 1 of 52 weeks.

17 Apr – 16 Oct

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1

Sale orders, 12 months7

Buyers · sellers1 · 6

Who	Did	Shares	Traded
Erik OstrowskiSVP, CFO, CBO & Treasurer	sold	56,019at $1.11	29 Jun 2026filed 1 Jul 2026
John P. ButlerCEO and President	bought	69,270at $1.25	4 Mar 2026filed 5 Mar 2026
John P. ButlerCEO and President	sold	46,660at $1.39	2 Feb 2026filed 4 Feb 2026
John P. ButlerCEO and President	sold	96,065at $1.39	2 Feb 2026filed 4 Feb 2026
John P. ButlerCEO and President	sold	114,891at $1.39	2 Feb 2026filed 4 Feb 2026
John P. ButlerCEO and President	sold	83,689at $1.39	2 Feb 2026filed 4 Feb 2026
Steven Keith BurkeSVP, Chief Medical Officer	sold	21,582at $1.39	2 Feb 2026filed 4 Feb 2026
Steven Keith BurkeSVP, Chief Medical Officer	sold	25,375at $1.39	2 Feb 2026filed 4 Feb 2026
Steven Keith BurkeSVP, Chief Medical Officer	sold	20,701at $1.39	2 Feb 2026filed 4 Feb 2026
Nicholas GrundChief Commercial Officer	sold	53,585at $1.39	2 Feb 2026filed 4 Feb 2026
Nicholas GrundChief Commercial Officer	sold	31,244at $1.39	2 Feb 2026filed 4 Feb 2026
Erik OstrowskiSVP, CFO, CBO & Treasurer	sold	34,951at $1.39	2 Feb 2026filed 4 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders164+4 on the quarter

New · exited38 · 35

Reported value$120.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	19,986,374$22.8M	+1,293,078+6.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	11,322,143$12.9M	+155,433+1.4%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026	9,151,524$10.4M	+7,358,904+410.5%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	6,727,302$7.7M	+275,050+4.3%
STATE STREET CORPreduced · filed 7 Aug 2026	5,390,853$6.1M	-6,223,153−53.6%
JACOBS LEVY EQUITY MANAGEMENT, INCadded · filed 14 Aug 2026	4,273,026$4.9M	+3,843,357+894.5%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026	3,689,167$4.2M	+86,340+2.4%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026	3,196,605$3.6M	+811,892+34.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	2,533,977$2.9M	+318,536+14.4%
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026	2,436,673$2.8M	+1,138,872+87.8%